why choose us

First received: October 14, 2023

Clinical Trial: Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Light Chain (AL) Amyloidosis

Study Type: INTERVENTIONAL


Official Title: Phase 1b Dose Expansion Study of NXC-201 for the Treatment of Patients With Relapsed or Refractory AL Amyloidosis

Brief Summary: Open-label Phase 1b Dose Escalation/Dose Expansion study exploring the safety and efficacy of NXC-201 in patients with relapsed or refractory light chain amyloidosis (AL).

Read more